🔗 Share this article

Treasury head Reeves has stated she is planning "specific measures to address cost of living issues" in next month's financial statement.

Speaking to the BBC, she stated that lowering price rises is a shared task of both the government and the central bank.

The UK's inflation rate is expected to be the most elevated among the Group of Seven developed nations this year and next.

Possible Energy Bill Interventions

Reports indicate the government could intervene to reduce utility costs, for example by cutting the present 5% level of VAT applied on energy supplies.

An additional possibility is to lower some of the regulatory levies currently included in household expenses.

Fiscal Constraints and Expert Expectations

The government will obtain the latest draft from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will reveal how much scope there is for these measures.

The consensus from the majority of analysts is that Reeves will have to announce tax increases or spending cuts in order to fulfill her declared borrowing rules.

Previously on the same day, estimates suggested there was a twenty-two billion pound gap for the chancellor to fill, which is at the more modest range of expectations.

"It is a collective responsibility between the central bank and the administration to bear down further on some of the causes of price increases," the Chancellor told reporters in Washington, at the yearly gatherings of the IMF and World Bank.

Tax Pledges and Global Issues

While much of the attention has been on likely tax rises, the chancellor said the latest data from the fiscal watchdog had not changed her commitment to campaign commitments not to raise tax levels on income tax, sales tax or social security contributions.

She blamed an "uncertain global environment" with rising international and commercial issues for the Budget revenue measures, probably to be directed on those "wealthiest."

International Trade Disputes

Commenting on apprehensions about the UK's economic relations with China she said: "The UK's security interests invariably take priority."

Last week's declaration by Chinese authorities to increase export controls on critical minerals and other resources that are essential for advanced tech production led US President Donald Trump to propose an further 100% import tax on goods from the Asian country, increasing the possibility of an full-scale trade war between the two economic giants.

The American finance chief labeled China's action "economic coercion" and "a international production control attempt."

Questioned on accepting the American proposal to participate in its conflict with the Asian nation, Reeves said she was "deeply worried" by Chinese measures and encouraged the Chinese government "to avoid restrictions and restrict access."

She said the decision was "damaging for the global economy and causes further obstacles."

"It is my opinion there are areas where we should challenge Chinese policies, but there are also significant chances to trade with China's economy, including banking sector and other areas of the economy. We've got to get that equilibrium right."

The chancellor also stated she was cooperating with other major economies "on our own essential resources plan, so that we are reduced dependence."

Health Service Drug Pricing and Investment

The Chancellor also recognized that the cost the National Health Service spends on drugs could rise as a consequence of current discussions with the Trump administration and its drugs companies, in exchange for lower tariffs and investment.

Some of the biggest global pharmaceutical manufacturers have said lately that they are either halting or scrapping projects in the UK, with several attributing the insufficient payments they are getting.

Last month, the Science Minister said the price the health service pays for medicines would must rise to stop companies and pharmaceutical investment leaving the UK.

Reeves stated to media: "We have seen as a result of the cost structure, that medical research, innovative medicines have not been offered in the United Kingdom in the extent that they are in other EU nations."

"We want to guarantee that people getting treatment from the NHS are able to obtain the best life-saving medicines in the world. And so we are reviewing all of that, and... seeking to attract more investment into Britain."